EU approves second COVID-19 vaccine

Following a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2.

Read more

Angelini Pharma to take over Arvelle Therapeutics

Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement.

Read more

COVID-19 test gives results within minutes

University of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results. 

Read more

Merry Christmas and a Happy New Year

Dear readers,

We wish all visitors to our news page a peaceful and healthy New Year and a successful start to the New Year.  Stay healthy! We will be back with the latest news from 4 January.

Best regards

Your editorial team of European Biotechnology Magazine

Read more

EMA greenlights BioNtech’s COVID-19 vaccine

Following a rapid FDA approval, the European drug authority EMA has recommended to conditionally  approve BioNTech’s mRNA vaccine BNT162b2 in the EU.

Read more

European Circular Bioeconomy Fund growing

Only two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing.

Read more

Novo Holdings creates Hemab

Danish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.

Read more

Transgene starts 2021 with a new CEO

Strasbourg-based Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer.

Read more

Biotech companies launch Biotech Austria

Austria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria.

Read more

How microplastic particles get into the body

Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells.

Read more